- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06600971
The Effect of Self Acupressure in Patients With Multiple Sclerosis
October 10, 2024 updated by: Gülden Atan, Yuzuncu Yıl University
The Effect of Self Acupressure on Fatigue and Sleep Quality in Patients With Multiple Sclerosis
Patients with MS use non-pharmacological methods as well as pharmacological methods in the treatment of their symptoms.
Acupuncture, acupressure, aquatherapy, reflexology and aromatherapy are also complementary and integrated methods frequently used in patients with MS.
Integrated methods, which have an important place in independent nursing practices, have been preferred in nursing practices in recent years due to their safety, ease of application and minimal side effects.
In addition, acupressure application is included in the Nursing Interventions Classification, and is a method that increases the independent functions of the nurse and improves patient-nurse interaction.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In addition to pharmacological methods, patients with MS also use non-pharmacological methods in the treatment of the symptoms they experience.
Acupuncture, acupressure, aquatherapy, reflexology and aromatherapy are also complementary and integrated methods frequently used in MS.
Integrated methods, which have an important place in independent nursing practices, have been preferred in nursing practices in recent years due to their safety, ease of application and minimal side effects.
In addition, acupressure application is included in the Nursing Interventions Classification (NIC), and is a method that increases the independent functions of the nurse and improves patient-nurse interaction.
In addition, it is reported that acupressure, which is used in symptom control, should be used in care plans by nurses because it is one of the integrated methods.
Acupressure, one of the integrated treatment methods used for many years, can be applied to increase sleep quality and reduce fatigue levels.
Acupressure is a massage technique based on the principle of applying pressure to specific points on the body using hands, fingers and stimulator tools.
It has been determined that acupressure, which is reported to be applied safely by nurses in the literature, is effective in controlling fatigue, pain, sleep quality, depression, anxiety, quality of life and stress levels of patients with MS.
Therefore, nurses should be able to apply integrated methods in the management of symptoms experienced by patients with MS in cooperation with other members of the healthcare team and inform patients about these methods.
It is believed that the results of the study to be conducted on this subject will contribute to nursing interventions in the symptom management of MS.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Van, Turkey
- Yuzuncu Yıl University , Faculty of health science
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Between the ages of 18-65,
- Those who can read and write,
- Those who can speak Turkish,
- Patients diagnosed with multiple sclerosis,
- Patients who do not have a neurological disease other than MS,
- Those who volunteer to participate in our study,
- Patients who are conscious and do not have a psychiatric health problem
Exclusion Criteria:
• Patients with nerve, soft tissue, vascular disease infections in their extremities, who have undergone surgery,
- Patients with bleeding problems, pacemaker or heart failure and a diagnosed condition, mass and flattening in the neck,
- Patients with a diagnosis other than MS (such as subarachnoid hemorrhage, aneurysm, dementia, a psychiatric disease),
- Patients who have had a hemorrhagic stroke,
- Patients with malignancy,
- Patients with vision and hearing problems,
- Patients who do not volunteer to participate in our study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: acupressure
The patients in the experimental group received acupressure application for a total of 8 sessions, 2 sessions per week.
The first application was performed in a room in the polyclinic by a researcher with an acupressure application certificate.
Immediately after the preparation phase, the researcher applied acupressure with the thumb in a certain order (Ht7-Ht7 and St36-St36) on each point to be pressed, in accordance with the acupressure application protocol, for a duration of 2 minutes.
Verbal communication was maintained during the procedure to ensure the patient's relaxation.
After the first application, the application was taught to the patient.
In addition, the researcher established a WhatsApp group for regular follow-up of the patients in the experimental group, and the video recording of the acupressure was sent to the patients and they were asked to watch it.
|
The patients in the experimental group received acupressure application for a total of 8 sessions, 2 sessions per week.
|
|
No Intervention: Control
During the study, it was explained to the control group that their fatigue and sleep quality levels would be monitored for four weeks without any intervention (other than routine treatment given by the physician).
Patients in this group were asked to fill out the Fatigue Severity Scale and the Richard-Campbell Sleep Scale at the beginning and again in the 4th week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fatigue Severity Scale
Time Frame: 4 weeks
|
The scale is a Likert type with 9 questions, and each question is rated from 1 (strongly disagree) to 7 (strongly agree).
The total score varies between 9-63, with total scores of 27 and above indicating fatigue.
|
4 weeks
|
|
Richard-Campbell Sleep Scale
Time Frame: 4 weeks
|
The scale consists of 6 items.
The items measure the depth of night sleep, the time it takes to fall asleep, the frequency of waking up, the time it takes to stay awake when you wake up, the quality of sleep, and the noise level in the environment.
A score of "0-25" indicates "very bad sleep", and a score of "76-100" indicates "very good sleep".
While the total score of the scale is calculated, the scores from the 5 items are added up, and the 6th item is not included in the total score evaluation.
The minimum score from the scale is 0 and the maximum score is 100.
An increase in the score from the scale indicates an increase in sleep quality.
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Gülden Atan, PHD, Faculty of health science, Yuzuncu Yıl University , Van, TURKEY.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 18, 2024
Primary Completion (Actual)
July 18, 2024
Study Completion (Actual)
September 3, 2024
Study Registration Dates
First Submitted
September 10, 2024
First Submitted That Met QC Criteria
September 17, 2024
First Posted (Actual)
September 19, 2024
Study Record Updates
Last Update Posted (Actual)
October 16, 2024
Last Update Submitted That Met QC Criteria
October 10, 2024
Last Verified
October 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MS-GULDEN
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on acupressure application
-
Esra SABANCI BARANSELCompletedPain | Anxiety | Episiotomy WoundTurkey
-
ÇİĞDEM ERGİNActive, not recruitingCOPD (Chronic Obstructive Pulmonary Disease)Turkey
-
Adiyaman University Research HospitalCompleted
-
Didem LafciNot yet recruitingSleep | Acupressure | Hemodialysis TreatmentTurkey
-
Mardin Artuklu UniversityCompletedAcupressure | Cold ApplicationTurkey (Türkiye)
-
American University of Beirut Medical CenterEnrolling by invitationSleep | Anxiety | SLEEP DISTURBANCES Nec in ICD9CMLebanon
-
China Medical University HospitalNational Science and Technology CouncilRecruitingIschemic Stroke | Sleep | Circadian Rhythm | Post-stroke Fatigue | Acupressure | Inflammatory CytokineTaiwan
-
University of MichiganNational Center for Complementary and Integrative Health (NCCIH)Completed
-
Tung Wah CollegeHospital Authority Hong Kong West ClusterNot yet recruitingObesity and Metabolic SyndromeHong Kong
-
Ataturk UniversityNot yet recruitingAcute Pain | Acupressure | Alternative Medicine | İnjection